Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic FactorsMatteo Santoni, Nicola Battelli, Michèle Milella et al.|Cancers|2019Cited by 31
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.Marianna Nuti, Paolo Marchetti, Ilaria Grazia Zizzari et al.|Journal of Clinical Oncology|2017Cited by 5